|
Press Releases
| |
2004
|
Displaying releases:
1-15 | 16-28
|
| |
Nov-29-2004
|
Palatin Technologies to Present at the Wall Street 15th Annual Analyst forum |
| |
Nov-19-2004
|
Palatin Technologies, Inc. Announces Expansion of Patent Portfolio in the Treatment of Sexual Dysfunction; New European Patent Granted for PT-141 |
| |
Nov-15-2004
|
Palatin Technologies’ Novel Small Molecule Melanocortin Agonist Demonstrates a Decrease in Food Intake and Body Weight without Causing Side Effects |
| |
Nov-09-2004
|
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2005 Results |
| |
Nov-05-2004
|
Palatin Technologies, Inc. to Report First Quarter, Fiscal Year 2005 Financial Results; Teleconference and Webcast on November 10th |
| |
Nov-01-2004
|
Palatin Technologies to Present at CIBC 15th Annual Health Care Conference |
| |
Oct-28-2004
|
Palatin Technologies Responds to Competitive Technologies’ Demand for Arbitration |
| |
Oct-20-2004
|
Palatin Technologies to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference |
| |
Oct-06-2004
|
Palatin Technologies to Present at Bio Emerging Company Investor Forum |
| |
Sep-14-2004
|
Palatin Technologies, Inc. Reports Fourth Quarter, Fiscal Year 2004 Results |
| |
Sep-10-2004
|
Palatin Technologies, Inc. to Report Fourth Quarter, Fiscal Year 2004 Financial Results & Host Teleconference and Webcast on September 14th |
| |
Aug-13-2004
|
King Pharmaceuticals and Palatin Technologies Announce Strategic Alliance to Jointly Develop and Commercialize Pt-141 as an Innovative Treatment for Sexual Dysfunction |
| |
Aug-06-2004
|
Palatin Technologies, Inc. Receives $2 Million Milestone Payment Related to the FDA Approval of NeutroSpec™ |
| |
Jul-06-2004
|
Palatin Technologies, Inc. Announces FDA Has Approved NeutroSpec™ |
| |
Jun-30-2004
|
Palatin Technologies, Inc. Announces Publication of PT-141 Effects on Female Sexual Behavior in the Proceedings of the National Academy of Sciences |
| |
 |
|
|
